Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)

This publication has 15 references indexed in Scilit:

• DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
  New England Journal of Medicine, 2006
• Cancer Statistics, 2005
  CA: A Cancer Journal for Clinicians, 2005
• Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
  European Journal of Cardio-Thoracic Surgery, 2004
• Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2004
• Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2003
• A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2000
• Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials
  The Lancet, 1998
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
  Journal of Clinical Oncology, 1986